Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.

Van de Walle J, Van Herzeele C, Raes A.

Drug Saf. 2010 Apr 1;33(4):261-71. doi: 10.2165/11319110-000000000-00000.

PMID:
20297859
2.

The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.

Robson WL, Leung AK, Norgaard JP.

J Urol. 2007 Jul;178(1):24-30. Epub 2007 May 11. Review.

PMID:
17574054
3.

Desmopressin 30 years in clinical use: a safety review.

Vande Walle J, Stockner M, Raes A, Nørgaard JP.

Curr Drug Saf. 2007 Sep;2(3):232-8. Review.

PMID:
18690973
4.

The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.

Kamperis K, Rittig S, Radvanska E, Jørgensen KA, Djurhuus JC.

J Urol. 2008 Aug;180(2):707-13; discussion 713-4. doi: 10.1016/j.juro.2008.04.047. Epub 2008 Jun 13.

PMID:
18554642
5.

A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.

Lottmann H, Froeling F, Alloussi S, El-Radhi AS, Rittig S, Riis A, Persson BE.

Int J Clin Pract. 2007 Sep;61(9):1454-60. Epub 2007 Jul 26.

PMID:
17655682
6.

Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.

Juul KV, Van Herzeele C, De Bruyne P, Goble S, Walle JV, Nørgaard JP.

Eur J Pediatr. 2013 Sep;172(9):1235-42. doi: 10.1007/s00431-013-1992-9. Epub 2013 May 16.

7.

Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.

De Guchtenaere A, Raes A, Vande Walle C, Hoebeke P, Van Laecke E, Donckerwolcke R, Vande Walle J.

J Urol. 2009 Jan;181(1):302-9; discussion 309. doi: 10.1016/j.juro.2008.09.040. Epub 2008 Nov 14.

PMID:
19013601
8.

Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-induced nocturnal enuresis.

Sarma S, Ward W, O'Brien J, Frost AD.

Aust N Z J Psychiatry. 2005 Oct;39(10):949. No abstract available.

PMID:
16168026
9.

Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.

Montaldo P, Tafuro L, Rea M, Narciso V, Iossa AC, Del Gado R.

BJU Int. 2012 Oct;110(8 Pt B):E381-6. doi: 10.1111/j.1464-410X.2011.10918.x. Epub 2012 Feb 7.

10.

Focus on desmopressin and enuresis: a review of literature.

Ferrara P, Vena F, Basile MC, Ianniello F, Gatto A.

Minerva Urol Nefrol. 2016 Feb;68(1):14-9. Epub 2014 Jul 3. Review.

PMID:
24990391
11.

Safety profile of desmopressin tablet for enuresis in a prospective study.

Van Herzeele C, De Bruyne P, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.

Adv Ther. 2014 Dec;31(12):1306-16. doi: 10.1007/s12325-014-0173-1. Epub 2014 Dec 12.

PMID:
25504157
13.

Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.

Lottmann H, Baydala L, Eggert P, Klein BM, Evans J, Norgaard JP.

Int J Clin Pract. 2009 Jan;63(1):35-45. doi: 10.1111/j.1742-1241.2008.01956.x.

PMID:
19125991
14.

Did the removal of the indication of nocturnal enuresis for intranasal desmopressin change prescribing practice?

Hoffmann F, Glaeske G, Steuber C.

Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):105-9. doi: 10.1002/pds.2070. Epub 2010 Nov 11.

PMID:
21182158
15.

Predictive parameters of response to desmopressin in primary nocturnal enuresis.

Van Herzeele C, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.

J Pediatr Urol. 2015 Aug;11(4):200.e1-8. doi: 10.1016/j.jpurol.2015.03.007. Epub 2015 May 21.

PMID:
26059526
16.

Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.

De Bruyne P, De Guchtenaere A, Van Herzeele C, Raes A, Dehoorne J, Hoebeke P, Van Laecke E, Vande Walle J.

Eur J Pediatr. 2014 Feb;173(2):223-8. doi: 10.1007/s00431-013-2108-2. Epub 2013 Aug 30.

PMID:
23989967
17.

Effect of 1-deamino 8-D-arginine vasopressin spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis.

Akoğlu E, Görür S, Atik E, Okuyucu S, Sangün O.

Int J Pediatr Otorhinolaryngol. 2006 Nov;70(11):1919-22. Epub 2006 Aug 9.

PMID:
16901550
18.

Combined laser acupuncture and desmopressin for treating resistant cases of monosymptomatic nocturnal enuresis: a randomized comparative study.

Moursy EE, Kamel NF, Kaseem AF.

Scand J Urol. 2014 Dec;48(6):559-64. doi: 10.3109/21681805.2014.922609. Epub 2014 Jun 9.

PMID:
24909996
19.

Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.

Berkenwald A, Pires J, Ellsworth P.

J Pediatr Urol. 2016 Aug;12(4):220.e1-6. doi: 10.1016/j.jpurol.2016.05.029. Epub 2016 Jun 11.

PMID:
27373215
20.

Supplemental Content

Support Center